Companies & Deals
Share
Digital asset investment firm Techemy Capital has launched of its Holistic ETH-BTC Portfolio in partnership with on-chain asset management company Enzyme Finance(formerly Melon Protocol). Powered by digital asset data infrastructure company Brave New Coin, the Holistic ETH-BTC Portfolio is an actively traded portfolio that provides exposure to Bitcoin and Ethereum price action using Techemy Capital’s long and short trading strategies, designed by its in-house trading team. The portfolio quantifies bullish or bearish conditions to add or subtract from each investor’s starting position, based on an assessment of on-chain activity, token age spent, and technical analysis. The Holistic ETH-BTC Portfolio executes trading decisions using the daily price chart on Brave New Coin’s Bitcoin Liquid Index (BLX) and Ethereum Liquid Index (ELX).
The portfolio is powered by Enzyme, an Ethereum-based infrastructure for on-chain asset management. Enzyme helps professional fund managers to build and scale their investing strategies with an emphasis on security; providing a safe, easy, and low-cost way to create and operate an investment strategy with built-in accounting tools. Enzyme connects fund managers to a pool of potential investors, making it easier to attract and build a community of supporters. It also provides access to a broad ecosystem of DeFi tokens and protocols. Enzyme is integrated with Chainlink price oracles, which enables reliable real-time pricing.
Key features of the Holistic ETH-BTC Portfolio include:
Disclaimer of Warranty
The information provided in this article is for general informational purposes only. We make no warranties about the completeness, reliability, and accuracy of this information. Read full disclaimer
The portfolio’s rotation of assets includes Wrapped Bitcoin ($wBTC), Ethereum ($ETH), USD Coin ($USDC), Inverse ETH ($iETH), and Inverse BTC ($iBTC). These inverse assets, powered by Synthetix, allow Techemy’s traders to profit from a decline in price of the underlying asset. Techemy is able to access deep liquidity across the entire Ethereum network thanks to Enzyme's integration with Paraswap, a Decentralised Exchange aggregator that optimises order routing and minimises slippage.
Following this launch, Techemy Capital will roll out a Managed DeFi Portfolio to offer investors an exposure to the entire DeFi ecosystem.
“Following the exceptional performance of Techemy Capital’s private DeFi Portfolio in 2020, we are excited to open this product through Enzyme to the broader investor community,” said Fran Strajnar, Founder of Techemy Capital and Brave New Coin. “We are looking forward to working with Enzyme and our growing number of exchange partners to deliver the highest-grade digital asset and DeFi investment products.”
Related Articles

Companies & Deals
Stripe’s Reported PayPal Interest: A Signal of Payments Consolidation With Stablecoins in Focus?

Companies & Deals
Riot Platforms Faces Investor Pressure to Accelerate AI Infrastructure Expansion

Companies & Deals
German Financial Innovation: Stuttgart Stock Exchange Merges with Tradias in €500M Deal
Editor's Picks

UAE Stablecoins: Why They Are Built to Travel, Not Stay Local
Walid Abou Zaki
Feb 28, 2026
8 min

The Central Bank of the UAE Clearing the Noise Around Article 62
Walid Abou Zaki
Feb 25, 2026
5 min

Europe’s Crypto Purge: Did Lithuania Just Kick Out Innovation — and is the UAE the Beneficiary?
Salma Naueihed
Feb 18, 2026
7 min
Read More Articles
In the Same Space

South Korea to test digital won deposit tokens for government subsidies
News Desk
Mar 19, 2026
6 min

SEC approves Nasdaq rule change for tokenized stock settlement
News Desk
Mar 19, 2026
5 min

UAE Digital Asset Ecosystem Builds Through Pressure as Financial System Holds Strong
Walid Abou Zaki
Mar 18, 2026
7 min

Bitcoin stalls below $75K as SEC clarity meets Powell risk
News Desk
Mar 18, 2026
4 min